• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用长期释放氟维司群的植入物来表征安全性、毒性和降低乳腺癌风险。

Characterizing safety, toxicity, and breast cancer risk reduction using a long-term fulvestrant eluting implant.

作者信息

Thomas Scott, Roche Elysia, Desai Pujan, Pawlowska Nela, Bauer Diana, Gingrich David, Hsu Emily, Deitchman Amelia N, Aweeka Fran, Munster Pamela N

机构信息

Division of Hematology and Oncology, University of California, 1450 3rd Street, San Francisco, CA, 94143, USA.

Laboratory Animal Resource Center, University of California, San Francisco, USA.

出版信息

Sci Rep. 2025 Jan 24;15(1):3028. doi: 10.1038/s41598-024-77186-z.

DOI:10.1038/s41598-024-77186-z
PMID:39848945
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11758070/
Abstract

For individuals at high risk of developing breast cancer, interventions to mitigate this risk include surgical removal of their breasts and ovaries or five years treatment with the anti-estrogen tamoxifen or aromatase inhibitors. We hypothesized that a silicone based anti-estrogen-eluting implant placed within the breast would provide the risk reduction benefit of hormonal therapy, but without the adverse effects that limit compliance. To this end, we demonstrate that when placed adjacent to mammary tissue in the 7,12-dimethylbenz[a]anthracene-induced rat breast cancer model a fulvestrant-eluting implant delays breast cancer with minimal systemic exposure. Using adult female sheep, surgical placement of fulvestrant-eluting implants was safe and did not elicit significant breast tissue pathology when placed at the base of the udder for directed elution into the mammary tissue. At 30 days of elution, fulvestrant was found to penetrate mammary tissue forming a concentration gradient beyond 15 mm from the implant. Consistent with the small animal rat study, minimal systemic fulvestrant biodistribution was found. Together, these studies provide the proof of principle that a breast indwelling fulvestrant-eluting implant can reduce the risk of breast cancer and limit systemic exposure, while penetrating and distributing through breast tissue.

摘要

对于有患乳腺癌高风险的个体,降低这种风险的干预措施包括手术切除乳房和卵巢,或使用抗雌激素他莫昔芬或芳香化酶抑制剂进行五年治疗。我们假设,置于乳房内的含硅抗雌激素洗脱植入物将提供激素治疗降低风险的益处,但不会产生限制依从性的不良反应。为此,我们证明,在7,12-二甲基苯并[a]蒽诱导的大鼠乳腺癌模型中,当将氟维司群洗脱植入物置于乳腺组织附近时,可延缓乳腺癌进展,且全身暴露最小。使用成年雌性绵羊,将氟维司群洗脱植入物手术放置在乳房基部以定向洗脱到乳腺组织中是安全的,且不会引发明显的乳腺组织病理学变化。在洗脱30天时,发现氟维司群穿透乳腺组织,形成距植入物超过15毫米的浓度梯度。与小动物大鼠研究一致,发现全身氟维司群的生物分布最小。总之,这些研究提供了原理证明,即乳房内植入氟维司群洗脱植入物可降低乳腺癌风险并限制全身暴露,同时穿透并分布于乳腺组织。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cea0/11758070/b80692a268bb/41598_2024_77186_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cea0/11758070/4c94edcfbab7/41598_2024_77186_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cea0/11758070/471f8d7c78cb/41598_2024_77186_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cea0/11758070/38b10b5a49ef/41598_2024_77186_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cea0/11758070/5ed634fc19aa/41598_2024_77186_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cea0/11758070/b80692a268bb/41598_2024_77186_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cea0/11758070/4c94edcfbab7/41598_2024_77186_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cea0/11758070/471f8d7c78cb/41598_2024_77186_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cea0/11758070/38b10b5a49ef/41598_2024_77186_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cea0/11758070/5ed634fc19aa/41598_2024_77186_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cea0/11758070/b80692a268bb/41598_2024_77186_Fig5_HTML.jpg

相似文献

1
Characterizing safety, toxicity, and breast cancer risk reduction using a long-term fulvestrant eluting implant.使用长期释放氟维司群的植入物来表征安全性、毒性和降低乳腺癌风险。
Sci Rep. 2025 Jan 24;15(1):3028. doi: 10.1038/s41598-024-77186-z.
2
A long-term fulvestrant eluting implant is safe, non-toxic, and reduces the risk of breast cancer in in vivo models.一种长期释放氟维司群的植入物在体内模型中是安全、无毒的,并且能降低患乳腺癌的风险。
Res Sq. 2023 Oct 23:rs.3.rs-3459372. doi: 10.21203/rs.3.rs-3459372/v1.
3
Fulvestrant for hormone-sensitive metastatic breast cancer.氟维司群用于激素敏感性转移性乳腺癌。
Cochrane Database Syst Rev. 2017 Jan 3;1(1):CD011093. doi: 10.1002/14651858.CD011093.pub2.
4
Different types of implants for reconstructive breast surgery.用于乳房重建手术的不同类型植入物。
Cochrane Database Syst Rev. 2016 May 16;2016(5):CD010895. doi: 10.1002/14651858.CD010895.pub2.
5
Systemic therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer.用于预防或治疗早期乳腺癌中芳香化酶抑制剂引起的肌肉骨骼症状的系统治疗。
Cochrane Database Syst Rev. 2022 Jan 10;1(1):CD013167. doi: 10.1002/14651858.CD013167.pub2.
6
Non-contraceptive oestrogen-containing preparations for controlling symptoms of premenstrual syndrome.用于控制经前综合征症状的含雌激素非避孕制剂。
Cochrane Database Syst Rev. 2017 Mar 3;3(3):CD010503. doi: 10.1002/14651858.CD010503.pub2.
7
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
8
Risk-reducing medications for primary breast cancer: a network meta-analysis.原发性乳腺癌的风险降低药物:一项网状荟萃分析。
Cochrane Database Syst Rev. 2019 Apr 29;4(4):CD012191. doi: 10.1002/14651858.CD012191.pub2.
9
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
10
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.

本文引用的文献

1
The impact of prophylactic mastectomy on sexual well-being: a systematic review.预防性乳房切除术对性健康的影响:一项系统综述。
Sex Med Rev. 2024 Mar 26;12(2):164-177. doi: 10.1093/sxmrev/qead054.
2
Germline Genetic Testing for Hereditary Breast and Ovarian Cancer: Current Concepts in Risk Evaluation.遗传性乳腺癌和卵巢癌的种系基因检测:风险评估的当前概念。
Cold Spring Harb Perspect Med. 2024 Aug 1;14(8):a041318. doi: 10.1101/cshperspect.a041318.
3
Awareness and Candidacy for Endocrine Prevention and Risk Reducing Mastectomy in Unaffected High-Risk Women Referred for Breast Cancer Risk Assessment.
转诊进行乳腺癌风险评估的未受影响的高危女性对内分泌预防和降低风险的乳房切除术的认知及候选情况
Ann Surg Oncol. 2024 Feb;31(2):981-987. doi: 10.1245/s10434-023-14566-1. Epub 2023 Nov 16.
4
Presurgical Oral Tamoxifen vs Transdermal 4-Hydroxytamoxifen in Women With Ductal Carcinoma In Situ: A Randomized Clinical Trial.术前口服他莫昔芬与透皮 4-羟他莫昔芬治疗乳腺导管原位癌的随机临床试验。
JAMA Surg. 2023 Dec 1;158(12):1265-1273. doi: 10.1001/jamasurg.2023.5113.
5
Is It All about Surface Topography? An Intra-Individual Clinical Outcome Analysis of Two Different Implant Surfaces in Breast Reconstruction.一切都与表面形貌有关吗?乳房重建中两种不同种植体表面的个体内临床结果分析。
J Clin Med. 2023 Feb 7;12(4):1315. doi: 10.3390/jcm12041315.
6
Cancer statistics, 2023.癌症统计数据,2023 年。
CA Cancer J Clin. 2023 Jan;73(1):17-48. doi: 10.3322/caac.21763.
7
Study of the Effect of Different Breast Implant Surfaces on Capsule Formation and Host Inflammatory Response in an Animal Model.不同乳房植入物表面对动物模型中包膜形成和宿主炎症反应影响的研究
Aesthet Surg J. 2023 Mar 15;43(4):506-515. doi: 10.1093/asj/sjac301.
8
Implantable Drug Delivery Systems and Foreign Body Reaction: Traversing the Current Clinical Landscape.可植入药物递送系统与异物反应:审视当前临床现状
Bioengineering (Basel). 2021 Dec 9;8(12):205. doi: 10.3390/bioengineering8120205.
9
Uptake of bilateral-risk-reducing-mastectomy: Prospective analysis of 7195 women at high-risk of breast cancer.双侧预防性乳房切除术的接受情况:7195 名高危乳腺癌女性的前瞻性分析。
Breast. 2021 Dec;60:45-52. doi: 10.1016/j.breast.2021.08.015. Epub 2021 Aug 26.
10
Silicone Breast Implant Coated with Triamcinolone Inhibited Breast-Implant-Induced Fibrosis in a Porcine Model.在猪模型中,涂有曲安奈德的硅胶乳房植入物可抑制乳房植入物诱导的纤维化。
Materials (Basel). 2021 Jul 14;14(14):3917. doi: 10.3390/ma14143917.